Dofetilde

Active Ingredient(s): Dofetilide
FDA Approved: * January 22, 2019
Pharm Company: * AUROBINDO PHARMA LTD
Category: Irregular Heartbeat (Arrhythmia)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Dofetilde Overview

Dofetilide is a class III antiarrhythmic agent.[1] It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing 125, 250, and 500 µg of dofetilide. It is not available in Europe[2] or Australia.[3] Due to the pro-arrhythmic potential of dofetilide, it is only available by prescription from physicians who have undergone specific training in the risks of treatment with dofetilide. In add...

Read more Dofetilde Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dofetilide

Recent Dofetilde Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dofetilide
  • Capsule: 0.125mg, 0.25mg, 0.5mg, 125mcg, 250mcg, 500mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Dofetilide or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 February 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA